Skip to main content

Apyx Medical Corp

APYX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000719135

No open-market purchases or sales by Apyx Medical Corp insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $95.6M in total; no superinvestor holds it.

Holders of 5% or more of APYX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apyx Medical Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of APYX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Nantahala Capital Management, LLC13G9.99%3.49M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

1 Schedule 13D or 13G filing on Apyx Medical Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on APYX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 20254:32 PM ETNantahala Capital Management, LLCand 2 others13G9.99%3.49M sharesNewDec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Apyx Medical Corp shares.

No Form 144 notices for Apyx Medical Corp are on file.